Using NIH-Validated Digital Precision Medicine Platform to Gain acceleration for highly competitive Clinical Research funding to improve In-Place Care
Speaker: Praduman Jain & Dave Klein, Vibrent Health, (Email: firstname.lastname@example.org)
Praduman Jain: Principal Investigator, NIH Precision Medicine Initiative (All of Us Research Program), Founder and CEO of Vibrent Health: Jain was trained as an electrical and systems engineer and has 25+ years of experience in developing products at the intersection of telecom, media and digital health. Under Jain’s leadership, the NIH has awarded Vibrent over $90+ million in funding since 2017 to build and manage a robust data collection and engagement technology platform for health and clinical research for one million people across the U.S. Jain is a member of the National Academies of Sciences, Engineering, and Medicine’s Roundtable on Genomics and Precision Health. Prior to founding Vibrent, Jain held various senior leadership roles at Sprint, Nextel, AOL, and VTech and launched many emerging products and services. He earned a BSEE and MSEE degrees, has 116 issued and pending patents and has authored several scientific publications.
Dave Klein: Principal Investigator, NIH Precision Medicine Initiative (All of Us Research Program) and Chief Product Officer of Vibrent Health: Dave focuses on products that sit at the intersection of technology, science and digital health. He leads a diverse set of functions including product management, data analytics, user experience design, user research, science communications and digital health programs. Prior to coming to Vibrent Health, Dave led the development of products that improve the lives of individuals and families at large companies such as Virgin Mobile, Nextel, Sprint, Time Warner Cable and innovative technology startups.